100
Participants
Start Date
December 17, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
Continuous glucose monitoring (CGM) device
All included study participants recieve a CGM sensor (Dexcom G7) to monitor blood glucose. The treatment team is blind for the CGM values; the gold standard for glucose control (POC interval measures) will be followed.
Zorggroep Twente Almelo, Almelo
Deventer Ziekenhuis, Deventer
Medisch Spectrum Twente, Enschede
Collaborators (1)
DexCom, Inc.
INDUSTRY
Pioneers in Healthcare
UNKNOWN
Kim Kamphorst
OTHER